Cardioperf SRL
Cardioperf reported total assets of 189,756 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of Cardioperf shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +63 % Total assets +59 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cardioperf's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 01 Aug 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 28 Nov 2023
- Year ended 31 Dec 2021filed on 01 Sep 2022
Cardioperf's financial analysis
- Solvency89.2%sector median: 66.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cardioperf
Cardioperf's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0521.874.648
- VAT number
- BE0521874648
- Peppol
- Registered · 0208:0521874648 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Mar 2013
- Registered office
- 1650 Beersel
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Nursing and midwifery activities (NACE 86940)
Cardioperf (SRL) has been based in Beersel since 2013, active in: nursing and midwifery activities. For 2025, it reports a net profit of 26,543 € and equity of 169,270 €; its revenue is not published. Its solvency stands at 89.2%, above the median of its sector (66.3%).
Companies similar to Cardioperf
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about Cardioperf
What is the revenue of Cardioperf?
Cardioperf files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cardioperf?
In Belgium, the VAT number is the company number prefixed with BE: BE0521874648 for Cardioperf, if the company is VAT-registered. Its company number (CBE) is 0521.874.648.
Where is the registered office of Cardioperf?
According to the CBE register, the registered office of Cardioperf is in 1650 Beersel.
What is the equity of Cardioperf?
At the close of the 2025 financial year, the equity of Cardioperf amounts to 169,270 €, a solvency of 89.2% of total assets.
Who manages Cardioperf?
The register lists 1 active mandates at Cardioperf. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cardioperf
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →